New Delhi, June 22 (IANS) Former Congress chief Rahul Gandhi on Tuesday released the party's 'White Paper' on management of Covid-19, accusing the Central government of not taking adequate measures to prevent and contain the pandemic.Releasing the document at a virtual press conference, he said: "This White Paper is a discussion that has taken place within the Congress structure and we have had a discussion with the experts and we have basically developed four pillars." The first, Gandhi said, "is the idea of understanding exactly what went wrong, which is the foundation of the White Paper". The second pillar is preparation for the third wave, which includes developing the critical infrastructure, including oxygen, and other elements."The third pillar... that we have been repeating again and again and again, is the idea of an economic assistance package. Covid is not just a biological phenomena, it is also an economic and social phenomena and that is why we have to make sure that the poorest people, the weakest people, small and medium businesses are provided support, that they need to get through and the fourth and final element is a Covid compensation fund, where we give money to people who have lost loved ones, where we commit to them support of the Indian nation and say 'look, we stand with you in this difficult time'," he said.The White Paper termed the "mismanagement of the Covid pandemic as India's gravest governance failure" and charged the Narendra Modi government with not taking adequate measures to prevent and contain the pandemic. It said that the Modi government's handling of the Covid-19 crisis began with its "early inaction" in January 2020, and how "ignored early warnings from experts and political leaders from the opposition". "It failed to learn from the lessons and response models of other countries which had been hit by the pandemic," it said, adding that the government did not scale up nationwide lessons from Kerala's experience in successfully suppressing the Nipah virus outbreak."This inaction for a period of nearly two months was completely avoidable and cost us dearly," it held.The White Paper suggested that the Modi government should have acted with seriousness and urgency after the outbreak of the pandemic in other countries, learnt from their lessons and followed the 3Ts -- Testing at scale, Tracing with diligence and Treating with precision.It also said that the government should have screened all international passengers and quarantined them as necessary from January 2020, and also tested symptomatic persons with no travel history. The Congress White Paper also criticised the government's initial response consisting of measures like the Janata Curfew, 'thali' clanging and 'diya' lighting, which did not adequately communicate the risks from Covid-19 to the public."It did not prepare them to undertake appropriate preventive measures. Instead, the Prime Minister announced a nationwide lockdown with only four hours' notice. It triggered a terrible humanitarian crisis impacting approximately four crore migrant workers and disrupted the livelihoods of poor families," it said. The Congress also came down hard on the PMCARES fund saying that it turned out to be an opaque entity with no transparency on utilisation of funds."The government ignored the suggestion of epidemiologists to conduct door-to-door screening to detect and curb the spread of the virus at the nascent stage," it said, adding that advice of experts about the ineffectiveness of lockdowns was also ignored.While the lockdown bought the government time to enhance testing and hospital facilities, its efforts on this front were "demonstrably inadequate", it said, and the "lockdown thus imposed severe social costs without the equivalent benefit of disease control". The Congress also said that the government should have decentralised resources, and empowered and equipped local authorities to arrest the spread of the virus and prepared a response plan ahead of time, based on the experience of other countries, including the earmarking of resources and the ramping up of infrastructural requirements such as hospital beds and medical oxygen."Two characteristics that stand out from the Modi government's handling of the pandemic are hubris and political avarice. The government declared victory over Covid-19 prematurely in early 2021. It deceptively used the 'Vaccine Maitri' scheme as a tool to project the Prime Minister's image globally, when the bulk of exports were contracts placed directly with private sector vaccine manufacturers," it said.Slamming the BJP, the Congress said: "At a time when large gatherings should not have been allowed, the ruling party demonstrated political avarice by conducting large election rallies during the eight phases of the assembly election in West Bengal, when the nation was already reeling from the second wave of the pandemic." It also cited the toppling of its government in Madhya Pradesh during the first wave of Covid, saying: "Earlier the Modi government denied that Covid-19 posed a major threat to public health until a Bharatiya Janata Party (BJP) government had been installed in Madhya Pradesh."It also said that the Modi government should have acted swiftly on warnings from scientists and the Indian SARS-CoV-2 Genomic Consortia (INSACOG) about contagious new variants of the virus, avoided declaring victory over Covid-19, which instilled a false sense of safety among the public, who believed their leaders and lowered their guard, banned large gatherings, including election rallies, and postponed panchayat elections in Uttar Pradesh.The White Paper also highlighted that the Modi government's practice of ignoring the signs and the science proved "disastrous". It said that the government notified ICMR, a research organisation, as the nodal agency to manage the pandemic instead of the battle-ready National Centre for Disease Control (NCDC) and National Institute of Virology (NIV). It also slammed the government for not rectifying "the under-reporting of the number of cases and deaths during both waves, crucial to frame policies based on accurate data", and BJP Ministers for not adequately assessing and preparing responses to the risks of community transmission."Further, its ministers publicly promoted unscientific remedies such as Coronil."--IANSaks/vd
Gurugram, April 25 (IANS) In view of the spike in Covid cases, the Haryana government announced that all IT sector and corporate offices in six districts -- Gurugram, Faridabad, Hisar, Panchkula, Karnal and Sonepat, would remain closed till May 3 up to 9 p.m.Also, the government offices in all districts will operate with 50 per cent strength. Even the industry has been asked to work in shifts.According to an order released by the chief secretary-cum-Chairperson Vijay Vardhan, no lockdown would be imposed in Gurugram and Faridabad. "Work-from-home should be followed, amid rise in covid infections," he said.An order in this regard was released late on Saturday night.All private hospitals have been asked to reserve 50 per cent beds for Covid patients. Earlier, the reservation was 40 per cent.After 6 p.m., the markets have been ordered to be closed. The maximum gathering in indoor programs has been reduced to 50 from 200.According to the order, the Deputy Commissioners (DCs) have been authorized to impose Section 144 wherever required. They have been asked to deal strictly wherever the cases are higher.Disobeying government order will initiate action against the offenders under relevant sections of the IPC, the order said.--IANSstr/skp/
New Delhi, April 6 (IANS) Occupancy recovery, along with cost control measures, will drive corporate healthcare's FY22 profitability, an India Ratings and Research (Ind-Ra) report said.It said the outlook for the hospital sub-sector is stable in view of robust demand drivers, moderation in capacity enhancement capex and improvement in profitability at new hospitals."Revenue recovery to FY20 level along with the focus of the management on cost control and significant moderation in capex is likely to improve with cash generation in FY22 with free cash flow generation turning to moderately positive," the Ind-Ra report said."However, continued international travel restrictions and intermittent local lockdowns owing to the resurgence of infections would continue to impact the hospitals located primarily in metros and Tier I cities which derive a considerable revenue share from the margin-accretive complex and elective surgeries as well as medical tourism."Besides, the report cited that amid increased competition in metros and Tier I cities, majority of the beds added by large hospital players over the last five years are in less-crowded Tier II cities which have seen a strong demand during the pandemic."The outlook for the diagnostic companies' sub-sector is also stable for FY22, supported by a quick recovery in operations from the Covid impact, robust cash generation and strong credit profiles.""While increasing competition and acquisition-led expansion could compress margin, the headroom available to absorb shock remains comfortable."According to the ratings agency, vaccination drive across the world and easing restrictions would lead to a recovery in the margin-accretive international patient mix."International patients generally make 8-10 per cent of the revenue which is likely to continue to be impacted till the travel restrictions are eased out.""The cost control measured taken by the sector companies for addressing the Covid impact during FY21 would enable them in addressing intermittent lock-downs and protecting the downside to EBITDA decline due to lower patient admissions."As per Ind-Ra, liquidity of sector companies will remain adequate in FY22, driven by a net cash position and the longer tenure repayments structure of over eight to 10 years."The deleveraging trend of the sector companies is likely to gain traction from FY22 after recovering from the impact of Covid in FY21.""Diagnostic sector companies have recorded a stronger recovery from 3QFY21 and also continue to have strong balance sheets to handle contingencies."In addition, medical devices sector which has seen an increased interest from the Indian government would see investments growing.However, the overall impact is likely to be seen over the long term, given the high complexity involved in manufacturing on account of quality requirements along with cost competitiveness.--IANSrv/sn/vd
New Delhi, June 3 (IANS) The Steel Authority of India Ltd (SAIL) on Wednesday said that some of its employees at its corporate office in the national capital's Lodhi Road have tested positive for novel coronavirus.Sources told IANS that five people have been found infected with the virus."The infected employees have been immediately asked to home quarantine themselves and Company's SOP to handle the Covid infection has been put into action. A Government appointed agency has been engaged to do fumigation at SAIL's HQ at Lodhi Road which is being carried out extensively for two days," the SAIL statement said.The office has been closed for Wednesday and Thursday, and the employees have been asked to work from home.SAIL has also tied up with two Max and Apollo hospitals in Delhi to facilitate testing of employees who require the same.Since the company restarted its office in a phased manner, all the required safety measures including sanitisation, thermal checking, hand sanitisers at touch points and fumigation as per requirement were in place, it said."Nevertheless, with the detection of corona positive cases, the company has taken all actions with greatest promptitude and is continuously monitoring the situation in consultation with the government agencies," said the statement.--IANSrrb/sn/vd
New Delhi, March 23 (IANS) The government has decided to include corporates' spending on checking coronavirus as part of the Corporate Social Responsibility.In a circular issued by the Ministry of Corporate Affairs, said that corporate spending for various activities related to Covid-19 including promotion of healthcare, preventive healthcare, sanitation, disaster management would qualify for treatment as CSR.The interpretation of the activities qualifying as CSR for Covid-19 will also be interpreted liberally to prevent red tape from squeezing fund flows.The corporate social responsibility rules make it mandatory for large Indian firms to set aside at least 2 per cent of their average net profit for socially responsible expenditures. The norms are applicable to firms with at least Rs 5 crore net profit or Rs 1,000 crore turnover or Rs 500 crore net worth. The list of activities included under CSR is decided by the government.With the approval to include Covid-19, which has been declared a global pandemic by WHO and a notified disaster by the Indian government, into CSR spent, huge fund flow is expected to come into the healthcare segment.The total corporate social responsibility (CSR) spending by the top 500 companies in the country since the applicability of mandatory CSR in 2014 is likely to cross Rs 60,000 crore by the end of month as per industry reports.--IANSsn/prs/in
आयुर्वेद क्षेत्र की दिग्गज भारतीय कंपनी डाबर इंडिया लिमिटेड को कॉरपोरेट गवर्नेंस में उत्कृष्टता के लिए अवार्ड मिला है. एक भव्य समारोह में बेस्ट गवर्नड कंपनीज श्रेणी के अंतर्गत डाबर को यह सम्मान मिला. आईसीएसआई (icsi) नेशनल अवार्ड फॉर एक्स्सेलेंस इन कॉर्पोरेट गवर्नेंस ( icsi national awards for excellence in corporate governance) का यह 18वां संस्करण था.
डाबर इण्डिया लिमिटेड भारत में आयुर्वेद और नेचुरल प्रोडक्ट बनाने वाली देश की बड़ी कंपनियों में से एक है. लंबे समय तक भारतीय बाजार पर इसका ही वर्चस्व रहा. हाल में इसे पातंजलि से बड़ी चुनौती मिली. लेकिन कुछ समय तक पातंजलि से आयुर्वेद प्रोडक्ट के मामले में पिछड़ने के बाद उसने दुबारा शानदार वापसी की है और अपने खोये हुए बाज़ार को पाने के अलावा उसका विस्तार भी किया है.
डाबर की कहानी - Dabur History
डाबर की शुरुआत बर्मन परिवार ने तब एक छोटी सी आयुर्वेदिक दवा कंपनी के रूप में शुरुआत की थी जो बाद में देश की सबसे बड़ी आयुर्वेदिक कंपनी के रूप में बनकर उभरी. उसके बाद तो कोलकाता के बर्मन परिवार की कंपनी डाबर इंडिया लिमिटेड ने अब पूरी दुनिया में अपना परचम लहरा दिया. आयुर्वेदिक व प्राकृतिक चिकित्सा के क्षेत्र में काम करते हुए कंपनी को 135 साल हो चुके हैं और इसके च्वयनप्राश और हाजमोला जैसे प्रोडक्ट भारतीय जनमानस के जुबां पर बैठ गए हैं. डाबर इंडिया के 250 से अधिक उत्पादों की बाजार में तूती बोल रही है। दवाई से लेकर फूड तक में हर जगह डाबर मौजूद दिखता है। डाबर इंडिया लिमिटेड भारत की अग्रणी एफएमसीजी कंपनियों में भी शुमार है, जिसका राजस्व 7,680 रूपये से अधिक और बाजार पूंजीकरण 48,800 करोड़ रुपये से अधिक है.डाबर आज प्रमुख उपभोक्ता उत्पाद श्रेणियों जैसे हेयर केयर, ओरल केयर, हेल्थ केयर, स्किन केयर, होम केयर और फूड्स में संचालित होता है. इसका व्यापक वितरण नेटवर्क है, जो शहरी और ग्रामीण दोनों बाजारों में समान रूप से है. डाबर के उत्पादों की विदेशी बाजारों में भी भारी उपस्थिति है और आज यह दुनिया भर में 120 से अधिक देशों में उपलब्ध है। इसके ब्रांड मध्य पूर्व, सार्क देशों, अफ्रीका, अमेरिका, यूरोप और रूस में अत्यधिक लोकप्रिय हैं। डाबर का विदेशी राजस्व आज कुल कारोबार का 30% है।